Cargando…
Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
INTRODUCTION: Reactivation of hepatitis B virus (HBV) infection in patients with past infection has been described in 5% to 10% of individuals undergoing immunosuppressive therapies. No data are available to date on the outcome of patients treated by tumour necrosis factor-alpha (TNFα) inhibitors fo...
Autores principales: | Charpin, Caroline, Guis, Sandrine, Colson, Philippe, Borentain, Patrick, Mattéi, Jean-Pierre, Alcaraz, Patrice, Balandraud, Nathalie, Thomachot, Benoit, Roudier, Jean, Gérolami, René |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003507/ https://www.ncbi.nlm.nih.gov/pubmed/19941642 http://dx.doi.org/10.1186/ar2868 |
Ejemplares similares
-
Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics
por: Silvy, Florent, et al.
Publicado: (2015) -
Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis
por: Charpin, Caroline, et al.
Publicado: (2010) -
Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
por: Balandraud, N, et al.
Publicado: (2005) -
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
por: Balandraud, Nathalie, et al.
Publicado: (2017) -
TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy
por: Guis, Sandrine, et al.
Publicado: (2016)